Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Clinical trial NCT03788434 · COMPLETED

Trial details

NCT number: NCT03788434
Sponsor: Vedanta Biosciences, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Clostridium Difficile Infection Recurrence Clostridium Difficile Infection Clostridium Difficile Clostridioides Difficile Infection Recurrence Clostridioides Difficile Infection Clostridioides Difficile CDI

Start date: 2019-02-08
Primary completion: 2021-06-02
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.